Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis.

Front Immunol · 2024 · PMC11521824 · PMID 39478857

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results of OS suggest that combination immunotherapy is highly significant in comparison to monotherapy or single immunotherapy in improving breast cancer management. 3.2.2 Progression-free survival We also analyzed progression-free survival in all four phases I, II, III, and IV RCTs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.